Allergic myocardial infarction

Cardiology Journal

Volumn 15, Issue 3, 2008, Pages 220-225

  Sinkiewicz, Władysław ^a,b   Sobański, Piotr ^b   Bartuzi, Zbigniew ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Hospital in Bydgoszcz   (Poland)

Author keywords

Allergic myocardial infarction; Anaphylactic shock; Immunotherapy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALLERGIC REACTION; ALLERGY; ANAPHYLAXIS; ANGINA PECTORIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; DESENSITIZATION; DRUG SUBSTITUTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART RHYTHM; HUMAN; IMMUNOTHERAPY; KOUNIS SYNDROME; OUTPATIENT CARE; PATHOPHYSIOLOGY; REVIEW; ACUTE CORONARY SYNDROME; ARTICLE; IMMUNOLOGY; VARIANT ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ANAPHYLAXIS; ANGINA PECTORIS, VARIANT; HUMANS; IMMUNOTHERAPY; MYOCARDIAL INFARCTION;

EID: 54049152883     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: the concept of allergic angina. Br J Clin Pract, 1991; 45: 121-128.
2. Braunwald E. Unstable angina. An etiologic approach to management. Circulation, 1998; 98: 2219-2222.
3. Lombardi A, Vandelli R, Cere E, Di Pasquale G. Silent acute myocardial infarction following a wasp sting. Ital Heart J, 2003; 4: 638-641.
4. Hamilos MI, Kochiadakis GE, Skalidis EI, Igoumenidis NE, Zaharaki A, Vardas PE. Acute myocardial infarction in a patient with normal coronary arteries after an allergic reaction. Hellenic J Cardiol, 2005; 46: 79-82.
5. Nittner-Marszalska M, Malolepszy J, Mlynarczewski A, Niedziolka A. Toxic reaction induced by Hymenoptera stings. Pol Arch Med Wewn, 1998; 100: 252-256.
6. Quercia O, Foschi FG, Marsigli L, Rafanelli S, Stefanini GF. Immunotherapy despite anaphylaxis-induced myocardial infarction. Allergy, 2001; 56: 89-90.
7. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol, 2006; 110: 7-14.
8. Zavras GM, Papadaki PJ, Kokkinis CE, Kalokairinov K, Kouni SN, Batsolaki M. Kounis syndrome secondary to allergic reaction following shellfish ingestion. Int J Clin Pract, 2003; 57: 622-624.
9. Maseri A. Coronary vasoconstriction: visible and invisible. N Engl J Med, 1991; 325: 1579-1580.
10. Nikolaidis LA, Kounis NG, Gradman AH. Allergic angina and allergic myocardial infarction: a new twist on an old syndrome. Can J Cardiol, 2002; 18: 508-511.
11. Ellis AK, Day JH. Clinical reactivity to insect stings. Curr Opin Allergy Clin Immunol, 2005; 5: 349-354.
12. Lopez-Minguez JR, Gonzalez Fernandez R, Millan Nunez V, Merchan Herrera. A, Altozano Gomez JC, Garcia-Andoain JM. Acute myocardial infarction secondary to anaphylactic reaction following shellfish ingestion. The need for rescue coronary angioplasty. Rev Esp Cardiol, 2000; 53: 1663-1666.
13. Weber S, Genevray B, Pasquier G, Chapsal J, Bonnin A, Degeorges M. Severe coronary spasm during drug-induced immediate hypersensitivity reaction. Lancet, 1982; 2: 821.
14. Crawley F, Schon F, Brown MM. Cerebral infarction: A rare complication of wasp sting. J Neurol Neurosurg Psychiatry, 1999; 66: 550-551.
15. Kounis NG, Grapsas ND, Goudevenos JA. Unstable angina, allergic angina, and allergic myocardial infarction. Circulation, 1999; 100: e156.
16. Szczeklik A, Nizankowski R, Mruk J. Myocardial infarction in status asthmaticus. Lancet, 1977; 1: 658-659.
17. Ewan PW. Venom allergy. BMJ 1998; 316: 1365-1368.
18. Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol, 1994; 25: 154-159.
19. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation, 1995; 92: 1084-1088.
20. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary+ artery. Circulation, 1999; 99: 361-369.
21. Constantinides P. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation, 1995; 92: 1083.
22. Kaartinen M, Penttila A, Kovanen PT. Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb, 1994; 14: 966-972.
23. Report from XVI European Congress of Alergology and Clinical Immunology, Madrid. Int Rev Allergol Clin Immunol, 1996; 2: 1-9.
24. Metzler B, Xu Q. The role of mast cells in atherosclerosis. Int Arch Allergy Immunol, 1997; 114: 10-14.
25. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science, 1984; 223: 1435-1437.
26. Pomerance A. Peri-arterial mast cells in coronary atheroma and thrombosis. J Pathol Bacteriol, 1958; 76: 55-70.
27. Cuculo A, Summaria F, Schiavino D, Liuzzo G, Meo A, Patriarca G. Tryptase levels are elevated during spontaneous ischemic episodes in unstable angina but not after the ergonovine test in variant angina. Cardiologia, 1998; 43: 189-193.
28. Kaartinen M, Penttila A, Kovanen PT. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation, 1996; 94: 2787-2792.
29. Kaartinen M, van der Wal AC, van der Loos CM, Piek JJ, Koch KT, Becker AE. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol, 1998; 32: 606-612.
30. Kounis NG, Zavras GM. Allergic angina and allergic myocardial infarction. Circulation, 1996; 94: 1789.
31. Marone G, de Crescenzo G, Florio G, Granata F, Dente V, Genovese A. Immunological modulation of human cardiac mast cells. Neurochem Res, 1999; 24: 1195-1202.
32. Marone G, de Crescenzo G, Marino J, Patella MA, Genovese A. The role of human heart mast cell in systemic and cardiac anaphylaxis. XVI European Congress of Allergology and Clinical Immunology, ECACI'95. 1995: 459-462.
33. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol, 1994; 23: 352-357.
34. Mayer S, Hillis LD. Prinzmetal's variant angina. Clin Cardiol 1998; 21: 243-246.
35. Sakata Y, Komamura K, Hirayama A, Nanto S, Kitakaze M, Hori M. Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. Am J Cardiol, 1996; 77: 1121-1126.
36. Ginsburg R, Bristow MR, Kantrowitz N, Baim DS, Harrison DC. Histamine provocation of clinical coronary artery spasm: Implications concerning pathogenesis of variant angina pectoris. Am Heart J, 1981; 102: 819-822.
37. Nelson BL, Dupont LA, Reid MJ. Prospective survey of local and systemic reactions to immunotherapy with pollen extracts. Ann Allergy, 1986; 56: 331-334.
38. Leung DYM, Sampson HA, Ynginger JW et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med, 2003; 348: 986-993.
39. Finkelman FD, Rothenberg MC, Brandt EB, Morris SC, Strait RT. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol, 2005; 115: 449-457.
40. Capurro N, Levi R. The heart as a target organ in systemic allergic reactions: comparison of cardiac analphylaxis in vivo and in vitro. Circ Res, 1975; 36: 520-528.
41. Levi R, Zavecz JH, Ovary Z. IgE-mediated cardiac hypersensitivity reactions. An experimental model. Int Arch Allergy Appl Immunol, 1978; 57: 529-534.
42. Booth BH, Patterson R. Electrocardiographic changes during human anaphylaxis. JAMA, 1970; 211: 627-631.
43. Sobański P, Sinkiewicz W, Malyszka P, Bartuzi Z. Myocardial infarction after a wasp sting. Cardiologic aspects of specific immunotherapy after allergic infarction. Alergia Astma Immunol, 2006; 11: 218-222.
44. Tankersley MS, Butler KK, Butler WK, Goetz DW. Local reactions during allergen immunotherapy do not require dose adjustment. J Allergy Clin Immunol, 2000; 106: 840-843.
45. Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, Zweiman B. Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology. J Allergy Clin Immunol, 1989; 84: 129-130.
46. Müller UR, Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol, 2005; 115: 606-610.
47. Stumpf JL, Shehab N, Patel AC. Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacother, 2006; 40: 699-703.
48. Tunon-de-Lara JM, Villanueva P, Marcos M, Taytard A. ACE inhibitors and anaphylactoid reactions during venom immunotherapy. Lancet, 1992; 340: 908.
49. Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol, 2007; 98: 57-63.